Obamacare’s Impact on Today’s and Tomorrow’s Taxpayers: A Heritage Report

At a time when the nation has nearly $17 trillion in national debt and is running annual trillion-dollar budget deficits, largely attributed to existing entitlements, Obamacare creates two new entitlements projected to cost nearly $1.8 trillion over the next decade.

While Obamacare is technically scored by the Congressional Budget Office CBO as a deficit reducer, when rational assumptions are made and budget gimmicks are omitted, the law is far from paid for, likely increasing future budget deficits and further burdening current taxpayers and future generations.

New Spending

The two main coverage components of Obamacare are a massive Medicaid expansion and new government subsidies to purchase coverage in the government-run state exchanges. The new spending on these provisions will cost taxpayers nearly $1.8 trillion from 2014 to 2023.

New Taxes and Penalties

Obamacare’s new spending is offset in part by the imposition of 18 new taxes and penalties. The CBO and the Joint Committee on Taxation project that Obamacare’s taxes will raise $771 billion in new government revenue from 2013 to 2022. The taxes have been phased in since the law’s passage, with a few still waiting to start.

Unrealistic Savings

Another major source of funding for Obamacare’s new entitlement spending comes from Medicare. Obamacare reduces Medicare reimbursements by an estimated $716 billion from 2013 to 2022, and that money is counted by the CBO as an offset for some of the law’s new spending.

Read entire report at Heritage.org

Leave a reply

Don't forget to check out the recent podcast and subscribe! Stay alert and follow to know the moment the show is LIVE.

Disclosure of Material Connection: Some of the links found on this website are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my listeners and readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”